TCTR20220927004已完成1 期
Clinical trial for identification of safety dose of coffee cherry concentrate in healthy volunteers
Mivana Company Limited0 个研究点目标入组 18 人开始时间: 2022年9月27日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Age 18 years old and above, 2. BMI <= 30 kg/m2, 3. healthy with normal vital signs), 4. no systemic diseases e.g. DM, obesity, liver diseases, kidney diseases, thyroid diseases, cancer, and autoimmune diseases, 5. normal blood biochemical parameters including CBC, liver function (AST, ALT, bilirubin), kidney function (BUN, creatinine), lipid profile (cholesterol, HDL, LDL, triglycerides), fasting blood glucose (FBS)
排除标准
- •1. coagulation problems e.g. hemophilia, idiopathic thrombocytopenia, leukemia, 2. taking anti-coagulants e.g. warfarin, 3. pregnant or plan to be pregnant, 4. breastfeeding, 5. alcohol intake > 14 drinks per week for males or > 7 drinks per week for females and cannot refrain from alcohol intake during the study, 6. smoking > 10 cigarettes/ day, 7. allergy to coffee or caffeine, 8. anemia (Hematocrit <40% in males, < 36% in female or Hemoglobin < 13 g/ dL in males, 12 < g/ dL in females, 9. critical condition, 10. infectious diseases
研究者
相似试验
已完成
1 期
Dose-escalation safety of novel fungal beta-glucanshealthy adult individualsbeta-GlucansPolysaccharidesOligosaccharidesFungiClinical TrialSafetyDietary SupplementsDose-escalation studyTCTR20240705004Institute of Nutrition, Mahidol University18
已完成
不适用
Clinical dose-finding study to assess the effect of ABAlifeTM on postprandial blood glucose profile in prediabetic subjects: randomized, multicentric, double-blind, placebo-controlled, cross-over study with different dosages combined with a 12-weeks follow-up phasePre-DiabetesDRKS00026093Anton Hübner GmbH & Co. KG61
已完成
不适用
A clinical trial for the validation of safety and efficacy of the implant-type tissue-engineered cartilage using autologous cells.Severe nasal deformity in orofacial cleft, that needs nasal augmentation and nasal tip correctionJPRN-UMIN000017734The University of Tokyo Hospital2
已完成
1 期
Clinical trial to examine the effective dose and the safety of [11C]K-2 synthesized by dedicated machine in healthy male volunteersHealthy volunteersJPRN-UMIN000026357Yokohama City University12
已完成
不适用
A single dose clinical trial to study the safety of ART-I02 in patients with arthritisarthritis10003816NL-OMON45686Arthrogen B.V.12